142 related articles for article (PubMed ID: 16775501)
1. Beneficial effects of combined benazepril-amlodipine on cardiac nitric oxide, cGMP, and TNF-alpha production after cardiac ischemia.
Siragy HM; Xue C; Webb RL
J Cardiovasc Pharmacol; 2006 May; 47(5):636-42. PubMed ID: 16775501
[TBL] [Abstract][Full Text] [Related]
2. Benazepril combined with either amlodipine or hydrochlorothiazide is more effective than monotherapy for blood pressure control and prevention of end-organ injury in hypertensive Dahl rats.
Zhou MS; Jaimes EA; Raij L
J Cardiovasc Pharmacol; 2006 Jul; 48(1):857-61. PubMed ID: 16891915
[TBL] [Abstract][Full Text] [Related]
3. [Expression of tumor necrosis factor-alpha in myocardium and dorsal root ganglion of coronary artery occlusion in rats].
Niu YL; Guo Z
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2007 Nov; 19(11):657-61. PubMed ID: 17996132
[TBL] [Abstract][Full Text] [Related]
4. [Study of effects of drugs on myocardial hypertrophy due to overload].
Wang GP; Cao RH; Du YG; Zhang ZY; Lü JY; Chen SL; Qiao ZD
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2005 Nov; 17(11):670-2. PubMed ID: 16297322
[TBL] [Abstract][Full Text] [Related]
5. Benazepril, an angiotensin-converting enzyme inhibitor, alleviates renal injury in spontaneously hypertensive rats by inhibiting advanced glycation end-product-mediated pathways.
Liu XP; Pang YJ; Zhu WW; Zhao TT; Zheng M; Wang YB; Sun ZJ; Sun SJ
Clin Exp Pharmacol Physiol; 2009 Mar; 36(3):287-96. PubMed ID: 19018797
[TBL] [Abstract][Full Text] [Related]
6. Tumor necrosis factor-alpha gene expression in diabetic nephropathy: relationship with urinary albumin excretion and effect of angiotensin-converting enzyme inhibition.
Navarro JF; Milena FJ; Mora C; León C; Claverie F; Flores C; García J
Kidney Int Suppl; 2005 Dec; (99):S98-102. PubMed ID: 16336586
[TBL] [Abstract][Full Text] [Related]
7. A calcium channel blocker amlodipine increases coronary blood flow via both adenosine- and NO-dependent mechanisms in ischemic hearts.
Asanuma H; Minamino T; Sanada S; Ogita H; Kim J; Fujita M; Hirata A; Tsukamoto O; Ogai A; Node K; Hori M; Tomoike H; Kitakaze M
J Mol Cell Cardiol; 2005 Oct; 39(4):605-14. PubMed ID: 16087189
[TBL] [Abstract][Full Text] [Related]
8. Angiotensin II receptors subtypes mediate diverse gene expression profile in adult hypertrophic cardiomyocytes.
Zhou J; Xu X; Liu JJ; Lin YX; Gao GD
Clin Exp Pharmacol Physiol; 2007 Nov; 34(11):1191-8. PubMed ID: 17880376
[TBL] [Abstract][Full Text] [Related]
9. Benazepril plus amlodipine or hydrochlorothiazide for hypertension.
Davis BR; Whelton PK;
N Engl J Med; 2009 Mar; 360(11):1148-9; author reply 1149-50. PubMed ID: 19283889
[No Abstract] [Full Text] [Related]
10. Benazepril plus amlodipine or hydrochlorothiazide for hypertension.
Strauss MH; Weinstein J; Newton GE
N Engl J Med; 2009 Mar; 360(11):1148; author reply 1149-50. PubMed ID: 19283888
[No Abstract] [Full Text] [Related]
11. Compensatory function of bradykinin B1 receptor in the inhibitory effect of captopril on cardiomyocyte hypertrophy and cardiac fibroblast proliferation in neonatal rats.
Zou J; Ren JH; Feng D; Wang H; Xu J
Chin Med J (Engl); 2008 Jul; 121(13):1220-5. PubMed ID: 18710643
[TBL] [Abstract][Full Text] [Related]
12. Effect of antihypertensive monotherapy and combination therapy on arterial distensibility and left ventricular mass.
Neutel JM; Smith DH; Weber MA
Am J Hypertens; 2004 Jan; 17(1):37-42. PubMed ID: 14700510
[TBL] [Abstract][Full Text] [Related]
13. [Cardioprotection of recombinant human erythropoietin pretreatment on ischemia-reperfused hearts and mechanism thereof: experiment with rats].
Liu XM; Jia Z; Zhou ZQ; Xu JG
Zhonghua Yi Xue Za Zhi; 2007 Sep; 87(35):2463-7. PubMed ID: 18067805
[TBL] [Abstract][Full Text] [Related]
14. Beneficial effects of the combination of amlodipine and losartan for lowering blood pressure in spontaneously hypertensive rats.
Choi SM; Seo MJ; Kang KK; Kim JH; Ahn BO; Yoo M
Arch Pharm Res; 2009 Mar; 32(3):353-8. PubMed ID: 19387578
[TBL] [Abstract][Full Text] [Related]
15. Angiotensin II type 2 receptor expression after vascular injury: differing effects of angiotensin-converting enzyme inhibition and angiotensin receptor blockade.
Barker TA; Massett MP; Korshunov VA; Mohan AM; Kennedy AJ; Berk BC
Hypertension; 2006 Nov; 48(5):942-9. PubMed ID: 16982965
[TBL] [Abstract][Full Text] [Related]
16. The calcium channel blocker amlodipine promotes the unclamping of eNOS from caveolin in endothelial cells.
Batova S; DeWever J; Godfraind T; Balligand JL; Dessy C; Feron O
Cardiovasc Res; 2006 Aug; 71(3):478-85. PubMed ID: 16814758
[TBL] [Abstract][Full Text] [Related]
17. Combined effects of an angiotensin converting enzyme inhibitor and a calcium antagonist on renal injury.
Bakris GL; Griffin KA; Picken MM; Bidani AK
J Hypertens; 1997 Oct; 15(10):1181-5. PubMed ID: 9350593
[TBL] [Abstract][Full Text] [Related]
18. Differential roles of dihydropyridine calcium antagonist nifedipine, nitrendipine and amlodipine on gentamicin-induced renal tubular toxicity in rats.
Li J; Li QX; Xie XF; Ao Y; Tie CR; Song RJ
Eur J Pharmacol; 2009 Oct; 620(1-3):97-104. PubMed ID: 19698708
[TBL] [Abstract][Full Text] [Related]
19. Complementary roles of tumor necrosis factor alpha and interferon gamma in inducible microglial nitric oxide generation.
Mir M; Tolosa L; Asensio VJ; Lladó J; Olmos G
J Neuroimmunol; 2008 Nov; 204(1-2):101-9. PubMed ID: 18703234
[TBL] [Abstract][Full Text] [Related]
20. Differential regulation of the nitric oxide-cGMP pathway exacerbates postischaemic heart injury in stroke-prone hypertensive rats.
Itoh T; Haruna M; Abe K
Exp Physiol; 2007 Jan; 92(1):147-59. PubMed ID: 17030559
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
